Date Name Title Filing Type Shares Traded Price Total Held
Dec 20, 2016
Director, President & CSO
Director, President & CSO Form 5 Bona fide gift 670 -- 65,130
Dec 20, 2016
Director, President & CSO
Director, President & CSO Form 5 Bona fide gift 536 -- 64,594
Dec 20, 2016
Director, President & CSO
Director, President & CSO Form 5 Bona fide gift 536 -- 64,058
Dec 14, 2010
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Form 4/A Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 -- 870,375
May 01, 2024
Director, Bd. Co-Chair, President & CSO
Director, Bd. Co-Chair, President & CSO Form 4 Other acquisition or disposition -- -- 752,486
May 01, 2024
Director, Bd. Co-Chair, President & CSO
Director, Bd. Co-Chair, President & CSO Form 4 Other acquisition or disposition -- -- 5,889
May 01, 2024
Director, Bd. Co-Chair, President & CSO
Director, Bd. Co-Chair, President & CSO Form 4 Other acquisition or disposition -- -- 121,071
May 01, 2024
Director, Bd. Co-Chair, President & CSO
Director, Bd. Co-Chair, President & CSO Form 4 Other acquisition or disposition -- -- 158,410
May 01, 2024
Director, Bd. Co-Chair, President & CSO
Director, Bd. Co-Chair, President & CSO Form 4 Other acquisition or disposition -- -- 886,383
May 01, 2024
Director, Bd. Co-Chair, President & CSO
Director, Bd. Co-Chair, President & CSO Form 4 Other acquisition or disposition -- -- 5,903

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.